Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori
Clinical trial NCT06412640 · UNKNOWN
Trial details
- NCT number
- NCT06412640
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2024-12-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.